ELAT - Elanco Animal Health Inc - Units ( Purchase Contract & Senior Amortizing Note)
Previous close
21.32
0 0%
Share volume: 674,440
Last Updated: Tue 31 Jan 2023 06:00:00 AM CET
Pharmaceutical Preparation Manufacturing :
-2.77%
PREVIOUS CLOSE
CHG
CHG%
$21.32
0.00
0.00%
Summary score
57%
Profitability
68%
Dept financing
0%
Liquidity
0%
Performance
75%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ELAT | VLON | RETA | CEREW |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 29.06% | 0% |
| Return on assets | 0% | 0% | -9.75% | 0% |
| Return on sales | 0% | 0% | -1469.44% | 0% |
| Return on invested capital | 0% | 0% | 47.78% | 0% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 0% | 0% | 183.15% | 0% |
| Debt ratio change over time | 0% | 0% | 19.02% | 0% |
| Dept financing | 0% | 0% | 50% | 0% |
| Current Ratio | 0% | 0% | 5.9% | 0% |
| Quick Ratio | 0% | 0% | 5.9% | 0% |
| Cash Position Ratio | 0% | 0% | 5.68% | 0% |
| Liquididy | 0% | 0% | 75% | 0% |
| Short-term ratios | ELAT | VLON | RETA | CEREW |
|---|---|---|---|---|
| Return on equity | 0% | 0% | -16.12% | 0% |
| Return on assets | 0% | 0% | -14.95% | 0% |
| Return on sales | 0% | 0% | -3498.94% | 0% |
| Return on invested capital | 0% | 0% | 96.56% | 0% |
| Profitability | 75% | 0% | 25% | 0% |
| Total debt ratio | 0% | 0% | 79.61% | 0% |
| Debt ratio change over time | 0% | 0% | 0.09% | 0% |
| Dept financing | 0% | 0% | 50% | 0% |
| Current Ratio | 0% | 0% | 5.9% | 0% |
| Quick Ratio | 0% | 0% | 5.9% | 0% |
| Cash Position Ratio | 0% | 0% | 5.68% | 0% |
| Liquididy | 0% | 0% | 75% | 0% |